Kieffer Tara Lynn - Insider Non-Derivative Transactions at ENANTA PHARMACEUTICALS INC (ENTA) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Dec 5, 2025, Kieffer Tara Lynn's relationship to ENANTA PHARMACEUTICALS INC (ENTA) is Officer (Chief Product Strategy Officer), and currently has 30,620 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other ENTA insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Kieffer Tara Lynn - Insider Non-Derivative Transactions of ENTA Common Stock

Kieffer Tara Lynn - Insider Non-Derivative Transactions at ENTA

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Dec 6, 2025	Sell -- (Common Stock)	2106	14.23	30620
Dec 2, 2025	F -- (Common Stock)	753	14.12	32726
Feb 13, 2025	F -- (Common Stock)	3326	5.59	33479
Feb 13, 2025	Acquisition -- (Common Stock)	7500	0	36805
Dec 7, 2024	Sell -- (Common Stock)	2283	8.06	29305
Dec 2, 2024	F -- (Common Stock)	753	8.6	31588
Jun 18, 2024	Sell -- (Common Stock)	7266	12.33	32341
Feb 13, 2024	F -- (Common Stock)	973	12.41	39607
Feb 13, 2024	Acquisition -- (Common Stock)	3320	0	40580
Dec 6, 2023	Sell -- (Common Stock)	2125	9.63	37260
Dec 2, 2023	F -- (Common Stock)	753	9.49	39385
Feb 14, 2023	Acquisition -- (Common Stock)	9250	0	35116
Feb 14, 2023	F -- (Common Stock)	6725	52.77	40138
Feb 14, 2023	Acquisition -- (Common Stock)	11747	0	46863